Also known as: AA-2414 / Bronica
Seratrodast is a selective thromboxane A2 (TXA2) receptor antagonist approved for the treatment of bronchial asthma. By blocking TXA2 receptors, it prevents bronchoconstriction, platelet aggregation, and airway inflammation. It is particularly effective in combination with other anti-asthmatic agents. Mediocon Inc produces GMP-certified Seratrodast API meeting IP/BP/EP/USP pharmacopoeial standards.
| Parameter | Specification |
|---|---|
| CAS Number | 142001-63-6 |
| Molecular Formula | C₂₂H₂₃ClO₄ |
| Molecular Weight | 406.87 g/mol |
| Grade | IP / BP / EP / USP |
| Category | Anti-asthmatic / Thromboxane A2 Receptor Antagonist |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Mfg Date | MAR 2025 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Seratrodast — CAS 142001-63-6 (CAS 142001-63-6) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Seratrodast — CAS 142001-63-6 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance